Thorp Clay Insider Trades

Insider Trading History

Track insider trading activity for Thorp Clay. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Clearside Biomedical
Clearside Biomedical CLSD
Director
Holding Value $72.2k 176,141 shares
Last Trade
Feb 24, 2025 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$13.8k 15,000 shares
$0.92
$0.41
Clearside Biomedical
Clearside Biomedical CLSD
Director
Holding Value $18.5k 45,000 shares
Last Trade
Jun 20, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$51.8k 45,000 shares
$1.15
$0.41
Clearside Biomedical
Clearside Biomedical CLSD
Director
Holding Value $16.6k 40,522 shares
Last Trade
Sep 25, 2023 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$8.6k 10,000 shares
$0.86
$0.41
Clearside Biomedical
Clearside Biomedical CLSD
Director
Holding Value $12.3k 30,000 shares
Last Trade
Jun 22, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$39.3k 30,000 shares
$1.31
$0.41
PhaseBio Pharmaceuticals
PhaseBio Pharmaceuticals PHAS
Director
Holding Value $2.57k 36,693 shares
Last Trade
May 19, 2023 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$263 3,750 shares
$0.07
$0.07
Clearside Biomedical
Clearside Biomedical CLSD
Director
Holding Value $12.5k 30,522 shares
Last Trade
Dec 21, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$14.3k 14,000 shares
$1.02
$0.41
Clearside Biomedical
Clearside Biomedical CLSD
Director
Holding Value $6.77k 16,522 shares
Last Trade
Dec 15, 2022 Purchase (Other)Another type of insider transaction reported on SEC Form 4.
$10.3k 8,522 shares
$1.21
$0.41
Clearside Biomedical
Clearside Biomedical CLSD
Director
Holding Value $1.45M 3,545,040 shares
Last Trade
Dec 15, 2022 Sale (Other)Another type of insider transaction reported on SEC Form 4.
$1.7M 1,406,507 shares
$1.21
$0.41
Clearside Biomedical
Clearside Biomedical CLSD
Director
Holding Value $12.3k 30,000 shares
Last Trade
Jun 22, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$48.6k 30,000 shares
$1.62
$0.41
PhaseBio Pharmaceuticals
PhaseBio Pharmaceuticals PHAS
Director
Holding Value $263 3,750 shares
Last Trade
May 19, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.16k 3,750 shares
$0.84
$0.07
Vigil Neuroscience
Vigil Neuroscience VIGL
Director
Holding Value $12.5M 1,556,030 shares
Last Trade
May 16, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$44.2k 14,893 shares
$2.97
$8.05
Vigil Neuroscience
Vigil Neuroscience VIGL
Director
Holding Value $24.2k 3,000 shares
Last Trade
Mar 28, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$21.6k 3,000 shares
$7.20
$8.05
Vigil Neuroscience
Vigil Neuroscience VIGL
Director
Holding Value $10.1M 1,254,335 shares
Last Trade
Jan 11, 2022 Purchase (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
$14.9M 1,254,335 shares
$11.86
$8.05
Vigil Neuroscience
Vigil Neuroscience VIGL
Director
Holding Value $12.2M 1,519,335 shares
Last Trade
Jan 11, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$3.14M 265,000 shares
$11.86
$8.05
PhaseBio Pharmaceuticals
PhaseBio Pharmaceuticals PHAS
Director
Holding Value $2.31k 32,943 shares
Last Trade
Aug 18, 2021 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$30k 10,000 shares
$3.00
$0.07
Clearside Biomedical
Clearside Biomedical CLSD
Director
Holding Value $10.3k 25,000 shares
Last Trade
Jun 10, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$77.8k 25,000 shares
$3.11
$0.41
PhaseBio Pharmaceuticals
PhaseBio Pharmaceuticals PHAS
Director
Holding Value $981 14,000 shares
Last Trade
Jun 03, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$49.4k 14,000 shares
$3.53
$0.07
Clearside Biomedical
Clearside Biomedical CLSD
Director
Holding Value $2.03M 4,951,547 shares
Last Trade
Feb 10, 2021 Sale (Open Market)Shares sold on the open market or in a private sale.
$146k 32,873 shares
$4.43
$0.41
Clearside Biomedical
Clearside Biomedical CLSD
Director
Holding Value $1.41M 3,433,521 shares
Last Trade
Feb 10, 2021 Sale (Open Market)Shares sold on the open market or in a private sale.
$146k 32,873 shares
$4.43
$0.41
PhaseBio Pharmaceuticals
PhaseBio Pharmaceuticals PHAS
Director
Holding Value $1.61k 22,943 shares
Last Trade
Nov 24, 2020 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$7k 2,000 shares
$3.50
$0.07

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up